1. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase. Boyer, P.L., S.J. Smith, X.Z. Zhao, K. Das, K. Gruber, E. Arnold, T.R. Burke, Jr., and S.H. Hughes. Journal of Virology, 2018. 92(13): e02203-02217. PMID[29643235]. PMCID[PMC6002700].
[PubMed]. HIV_06_2018.
2. Antiviral Activity of HIV gp120-targeting Bispecific T Cell Engager Antibody Constructs. Brozy, J., E. Schlaepfer, C.K.S. Mueller, M.A. Rochat, S.K. Rampini, R. Myburgh, T. Raum, P. Kufer, P.A. Baeuerle, M. Muenz, and R.F. Speck. Journal of Virology, 2018. 92(14): e00491-00418. PMID[29720517].
[PubMed]. HIV_06_2018.
3. The Design, Synthesis and Structure-Activity Relationships Associated with C28 Amine-based Betulinic acid Derivatives as Inhibitors of HIV-1 Maturation. Chen, Y., S.Y. Sit, J. Chen, J.J. Swidorski, Z. Liu, N. Sin, B.L. Venables, D.D. Parker, B. Nowicka-Sans, Z.Y. Lin, Z.F. Li, B.J. Terry, T. Protack, S. Rahematpura, U. Hanumegowda, S. Jenkins, M. Krystal, I.D. Dicker, N.A. Meanwell, and A. Regueiro-Ren. Bioorganic & Medicinal Chemistry letters, 2018. 28(9): p. 1550-1557. PMID[29631960].
[PubMed]. HIV_06_2018.
4. Structure-based Lead Optimization to Improve Antiviral Potency and ADMET Properties of Phenyl-1H-pyrrole-carboxamide Entry Inhibitors Targeted to HIV-1 gp120. Curreli, F., D.S. Belov, Y.D. Kwon, R. Ramesh, A.M. Furimsky, K. O'Loughlin, P.C. Byrge, L.V. Iyer, J.C. Mirsalis, A.V. Kurkin, A. Altieri, and A.K. Debnath. European Journal of Medicinal Chemistry, 2018. 154: p. 367-391. PMID[29860061]. PMCID[PMC5993640].
[PubMed]. HIV_06_2018.
5. Friedelane Triterpenoids: Transformations toward A-Ring Modifications Including 2-Homoderivatives. Das, J., A. Sarkar, and P. Ghosh. New Journal of Chemistry, 2018. 42(9): p. 6673-6688. ISI[000431819200016].
[WOS]. HIV_06_2018.
6. Terpenes from Euphorbia antiquorum and Their in Vitro anti-HIV Activity. Dong, M., X.-Q. Chen, C.-H. Chen, and R.-T. Li. Chemistry & Biodiversity, 2018. 15(5): e1700560. PMID[29569369].
[PubMed]. HIV_06_2018.
7. HIV Transmission from Infected CD4+ T Cells to Allogenic T and Dendritic Cells Is Inhibited by Broadly Neutralizing Antibodies. Ducloy, C., B. Su, L. Mayr, J. Klingler, T. Decoville, S. Schmidt, G. Laumond, N. Salome, S. Bahram, and C. Moog. AIDS, 2018. 32(10): p. 1239-1245. PMID[29683853].
[PubMed]. HIV_06_2018.
8. ECD4-Ig Variants That More Potently Neutralize HIV-1. Fetzer, I., M.R. Gardner, M.E. Davis-Gardner, N.R. Prasad, B. Alfant, J.A. Weber, and M. Farzan. Journal of Virology, 2018. 92(12): e02011-02017. PMID[29593050]. PMCID[PMC5974481].
[PubMed]. HIV_06_2018.
9. Study on Dual Inhibitors of HIV-1 IN/CCR5 Caffeoyl Derivatives as Neuroprotective Agents. Hao, Y., B. Wu, Y. Chen, X. Sun, Y. Sun, J. Liu, and X. Wang. ChemistrySelect, 2018. 3(22): p. 6170-6173. ISI[000435260800022].
[WOS]. HIV_06_2018.
10. Identification of Highly Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors against Lopinavir and Darunavir Resistant Viruses from Allophenylnorstatine-based Peptidomimetics with P2 Tetrahydrofuranylglycine. Hidaka, K., T. Kimura, R. Sankaranarayanan, J. Wang, K.F. McDaniel, D.J. Kempf, M. Kameoka, M. Adachi, R. Kuroki, J.T. Nguyen, Y. Hayashi, and Y. Kiso. Journal of Medicinal Chemistry, 2018. 61(12): p. 5138-5153. PMID[29852069].
[PubMed]. HIV_06_2018.
11. HBV Polymerase-derived Peptide Exerts an anti-HIV-1 Effect by Inhibiting the Acetylation of Viral Integrase. Kim, H., S.Y. Lee, Y.M. Choi, and B.J. Kim. Biochemical and Biophysical Research Communications, 2018. 501(2): p. 541-546. PMID[29752938].
[PubMed]. HIV_06_2018.
12. Design, Synthesis and Biological Evaluation of Substituted (+)-SG-1 Derivatives as Novel anti-HIV Agents. Liu, X., P. Chen, X. Li, M. Ba, X. Jiao, Y. Guo, and P. Xie. Bioorganic & Medicinal Chemistry Letters, 2018. 28(10): p. 1699-1703. PMID[29699924].
[PubMed]. HIV_06_2018.
13. The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K is Species Specific. Lodermeyer, V., G. Ssebyatika, V. Passos, A. Ponnurangam, A. Malassa, E. Ewald, C.M. Sturzel, F. Kirchhoff, M. Rotger, C.S. Falk, A. Telenti, T. Krey, and C. Goffinet. Journal of Virology, 2018. 92(14): e00226-00218. PMID[29743357].
[PubMed]. HIV_06_2018.
14. Asymmetric Synthesis of Potential Precursors of the HIV Drug MC1220 and Its Analogues by Hydrogenation of (1-Arylvinyl)pyrimidines. Loksha, Y.M. and E.B. Pedersen. Journal of Heterocyclic Chemistry, 2018. 55(6): p. 1352-1357. ISI[000435277300011].
[WOS]. HIV_06_2018.
15. 4-Ethynyl-2-fluoro-2-deoxyadenosine, MK-8591: A Novel HIV-1 Reverse Transcriptase Translocation Inhibitor. Markowitz, M. and S.G. Sarafianos. Current Opinion in HIV and AIDS, 2018. 13(4): p. 294-299. PMID[29697468].
[PubMed]. HIV_06_2018.
16. Synthesis, Characterization and Biological Evaluation of Pd(II), Cu(II), Re(I) and Tc-99m(I) Thiazole-based Complexes. Maskovic, J.M., A. Hatzidimitriou, A. Damjanovic, T.P. Stanojkovic, S.R. Trifunovic, A.A. Geronikaki, and D. Papagiannopoulou. MedChemComm, 2018. 9(5): p. 831-842. ISI[000433259600008].
[WOS]. HIV_06_2018.
17. In Vitro Evaluation of Structural Analogs of Diallyl sulfide as Novel CYP2E1 Inhibitors for Their Protective Effect against Xenobiotic-induced Toxicity and HIV Replication. Rahman, M.A., Y.Q. Gong, and S. Kumar. Toxicology Letters, 2018. 292: p. 31-38. PMID[29694836].
[PubMed]. HIV_06_2018.
18. Identification of Novel HIV-1 Latency-reversing Agents from a Library of Marine Natural Products. Richard, K., D.E. Williams, E.D. de Silva, M.A. Brockman, Z.L. Brumme, R.J. Andersen, and I. Tietjen. Viruses, 2018. 10(7): E348. PMID[29954099].
[PubMed]. HIV_06_2018.
19. Facile Synthesis of Highly Functionalized Novel Pyrazolopyridones Using Oxoketene dithioacetal and Their anti-HIV Activity. Savant, M.M., K.D. Ladva, and A.B. Pandit. Synthetic Communications, 2018. 48(13): p. 1640-1648. ISI[000434688100007].
[WOS]. HIV_06_2018.
20. Synthesis, Biophysical Characterization, and anti-HIV-1 Fusion Activity of DNA Helix-based Inhibitors with a P-Benzyloxyphenyl Substituent at the 5'-Nucleobase Site. Tang, Y., Z. Han, J. Guo, Y. Tian, K. Liu, and L. Xu. Bioorganic & Medicinal Chemistry Letters, 2018. 28(10): p. 1842-1845. PMID[29680665].
[PubMed]. HIV_06_2018.
21. Rhodanine Derivatives as Potent anti-HIV and anti-HSV Microbicides. Tintori, C., G. Iovenitti, E.R. Ceresola, R. Ferrarese, C. Zamperini, A. Brai, G. Poli, E. Dreassi, V. Cagno, D. Lembo, F. Canducci, and M. Botta. Plos One, 2018. 13(6): e0198478. PMID[29870553].
[PubMed]. HIV_06_2018.
22. A New Saponin with anti-HIV-1 Protease Activity from Acacia pennata. Van-Dung Nguyen, Hong-Loan Thi Nguyen, Linh-Chi Do, Vu Van Tuan, Phuong Thien Thuong, and Tuan-Nghia Phan. Natural Product Communications, 2018. 13(4): p. 411-414. ISI[000433651900008].
[WOS]. HIV_06_2018.
23. Quantitative Structure-Activity Relationship Study of Betulinic acid Derivatives against HIV Using SMILES-based Descriptors. Worachartcheewan, A., A.P. Toropova, A.A. Toropov, S. Siriwong, J. Prapojanasomboon, V. Prachayasittikul, and C. Nantasenamat. Current Computer-Aided Drug Design, 2018. 14(2): p. 152-159. PMID[29332601].
[PubMed]. HIV_06_2018.
24. 3-Hydroxyphthalic anhydride- Modified Rabbit anti-PAP IgG as a Potential Bifunctional HIV-1 Entry Inhibitor. Zhang, X., J. Chen, F. Yu, C. Wang, R. Ren, Q. Wang, S. Tan, S. Jiang, S. Liu, and L. Li. Frontiers in Microbiology, 2018. 9: p. 1330. PMID[29971062]. PMCID[PMC6018217].
[PubMed]. HIV_06_2018.
Patent Citations
25.Preparation of Tricyclic Heterocycle Compounds Useful as HIV Integrase Inhibitors. Graham, T.H., T. Yu, S.T. Waddell, and J.A. McCauley. Patent. 2018. 2017-US64116 2018102634: 105pp.
[Patent]. HIV_06_2018.
26. Preparation of Tetracyclic Heterocycle Compounds Useful as HIV Integrase Inhibitors. Graham, T.H., T. Yu, Y. Zhang, and J.A. McCauley. Patent. 2018. 2017-US63831 2018102485: 168pp.
[Patent]. HIV_06_2018.
27. Preparation of Nucleoside Triphosphate and Nucleoside Triphosphate Analog Prodrugs as Antiviral Agents. Meier, C., T. Nack, T. Dinis de Oliveira, and C. Zhao. Patent. 2018. 2017-EP81140 2018100137: 85pp.
[Patent]. HIV_06_2018.